Patents
More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)
Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
05/2008
05/15/2008US20080114281 Transdermal Delivery System for Polynucleotides
05/14/2008CN101177456A Modified transferrin fusion proteins
05/14/2008CN101177455A Modified transferrin fusion proteins
05/13/2008US7371526 Reacting nucleic acids with magnesium/sodium bisulfite in presence of polyamine catalyst (guanidine) to create point mutations; kits
05/13/2008CA2293470C Benzimidazole derivatives
04/2008
04/22/2008US7361744 Oligosaccharide derivative
04/17/2008US20080090844 Infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus; Immunomodulators; antiviral and antitumor agents; modulation of cytokine receptors; improved oral tolerability
04/02/2008EP1905829A2 Templated molecules and methods for using such molecules
04/02/2008CN100378118C Pharmaceutical compositions having appetite suppressant activity
03/2008
03/25/2008US7348146 Single nucleotide polymorphism analysis of highly polymorphic target sequences
03/12/2008CN100374454C preparation method of 2-aminocarbonyl-9h-purine derivatives and intermediate thereof
03/11/2008US7342003 Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
02/2008
02/27/2008EP1891270A1 Paper pigment, process for producing a paper product and paper product
02/05/2008CA2223821C Magnetic particles with a glass surface and their use
01/2008
01/31/2008US20080027023 Antiproliferative Compositions Comprising Aryl Substituted Xylopyranoside Derivatives
01/29/2008CA2471775C Targeted cytotoxic anthracycline analogs
01/16/2008CN100362010C Mevalonic acid derivative
01/09/2008CN101099745A Methods and compositions for treating flaviviruses and pestiviruses
01/09/2008CN100360548C Oligosaccharide derivative
01/02/2008EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs
12/2007
12/27/2007US20070299028 Backbone modifications to modulate oligonucleotide targeting in vivo
12/12/2007CN100354296C Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same and method forproducing said compound
12/12/2007CN100354294C Crystal forms of azithromycin
11/2007
11/29/2007US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
11/21/2007CN101076537A Oligonucleotides labeled with a plurality of fluorophores
11/13/2007CA2402707C Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/08/2007US20070258890 Anthracycline Derivatives
10/2007
10/16/2007CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/11/2007US20070238866 Methods of producing c-aryl glucoside sglt2 inhibitors
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP0915880B1 Azolo triazines and pyrimidines
10/10/2007CN101052414A Immunogenic HBc chimer particles having enhanced stability
09/2007
09/19/2007EP1407044B1 Rna interference mediating small rna molecules
09/18/2007CA2348948C .beta.-l-2'-deoxy-nucleosides for the treatment of hiv infection
09/12/2007CN101033242A Antenna system for a level measurement apparatus
08/2007
08/22/2007EP1402024B1 Templated molecules and methods for using such molecules
08/21/2007CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
08/16/2007WO2005051967A3 Oligonucleotides labeled with a plurality of fluorophores
08/14/2007CA2334656C Method for preparing aloin by extraction
07/2007
07/25/2007CN101006177A An improved method for synthesising templated molecules
07/18/2007CN101001865A Purine nucleotide derivatives
07/10/2007CA2283564C Pharmaceutical compositions having appetite suppressant activity
06/2007
06/06/2007CN1974781A Enzyme reaction method for nucleic acid and composition for separating nucleic acid
05/2007
05/31/2007WO2005058930A3 Methods for production of recombinant vascular endothelial cell growth inhibitor
05/24/2007US20070117772 Methods for slowing familial ALS disease progression
05/16/2007CN1315862C Methods and compositions for treating flaviviruses and pestiviruses
05/02/2007CN1956992A Anthracycline derivatives
04/2007
04/26/2007US20070093445 RNA interference mediating small RNA molecules
04/18/2007EP1352063B1 Receptor nucleic acids and polypeptides
04/10/2007US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
04/04/2007CN1940068A Novel receptor nucleic acids and polypeptides
04/03/2007US7199106 Lincomycin derivatives possessing antimicrobial activity
03/2007
03/28/2007EP1765844A2 Purine nucleotide derivatives
03/28/2007EP1765363A2 New compositions
03/27/2007US7196209 Continuous process for the preparation of fructopyranose sulfamate derivatives
03/15/2007US20070060536 Novel reagent compounds and methods of making and using the same
03/14/2007EP1761550A2 Small molecule stimulators of neuronal growth
03/08/2007DE112004002170T5 Verbesserte Verfahren und Zusammensetzungen für RNA Interferenz Improved methods and compositions for RNA interference
02/2007
02/22/2007WO2005047300A3 Improved methods and compositions for rna interference
02/21/2007EP1753774A2 2"-nitrobenzyl-modified ribonucleotides
02/15/2007WO2005056570A3 Production of amino sugars
02/15/2007US20070037773 Methods and compositions for treating flaviviruses and pestiviruses
02/15/2007US20070037144 Leukocyte expression profiling
02/14/2007CN1300165C 3-b-d-ribofuranosylthiazolo [4,5-d] pyridimine nucleosides and uses thereof
02/13/2007CA2123241C Nucleosides and oligonucleotides having 2'ether groups
02/01/2007US20070027101 Treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy
01/2007
01/25/2007US20070020652 Methods and compositions for RNA interference
01/23/2007US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction
01/17/2007CN1896088A C-芳基葡糖苷sglt2抑制剂 C- aryl glucoside sglt2 inhibitors
01/16/2007US7163929 Methods and compositions for treating flaviviruses and pestiviruses
01/10/2007EP1740599A1 Anthracycline derivatives
01/10/2007EP1355916B1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
01/10/2007CN1891833A Enzyme reaction method for nucleic acid and composition for separating nucleic acid
01/04/2007US20070003963 RNA sequence-specific mediators of RNA interference
01/04/2007US20070003962 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response
01/04/2007US20070003961 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response
01/04/2007US20070003960 Producing knockdown cells; Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response
01/03/2007CN1293086C Fabric softening composition
12/2006
12/27/2006EP1736478A1 Methods and compositions for treating flaviviruses and pestiviruses
12/21/2006WO2006134211A1 Paper pigment, process for producing a paper product and paper product
12/21/2006CA2611555A1 Paper pigment, process for producing a paper product and paper product
12/12/2006US7148206 Methods and compositions for treating flaviviruses and pestiviruses
12/06/2006CN1872869A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase
12/05/2006CA2434386C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/2006
11/23/2006US20060264390 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
11/08/2006EP1718362A2 Transdermal delivery system for polynucleotides
11/02/2006EP0973534B1 Plant extracts having appetite suppressant activity
10/2006
10/31/2006CA2412554C 3-substituted morphines
10/26/2006US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity
10/26/2006US20060240519 Novel receptor nucleic acids and polypeptides
10/26/2006US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
10/26/2006US20060240517 Novel receptor nucleic acids and polypeptides
10/24/2006US7125950 Making bio-based polyurethanes by reacting a polyesterpolyol transesterification reaction product of a natural oil and a polyhydroxy compound such as sorbitol, with potassium hydroxide catalyst, with an isocyanate; renewable polymer; cost effective process
10/24/2006US7125855 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/12/2006US20060229260 Substituted fused heterocyclic C-glycosides
10/04/2006EP1707571A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/04/2006CN1839873A Pharmaceutically active uridine esters
09/2006
09/28/2006WO2005069736A3 Transdermal delivery system for polynucleotides
09/28/2006WO2005028489A3 Novel adenosine a3 receptor agonists
09/26/2006US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto
1 2 3 4 5 6 7 8 9 10 11 12